+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 119 Pages
  • May 2023
  • Region: Global
  • GlobalData
  • ID: 5823107
The publisher's Medical Devices sector report, 'Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A VNS is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically-implanted electrodes to target the vagus nerve.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Vagus Nerve Stimulators (VNS) Overview
3 Products under Development
3.1 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
3.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
3.3 Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
3.4 Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
3.5 Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
4 Vagus Nerve Stimulators (VNS) - Pipeline Products under Development by Companies
4.1 Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
4.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
5 Vagus Nerve Stimulators (VNS) Companies and Product Overview6 Vagus Nerve Stimulators (VNS)- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
  • Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
  • Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
  • Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
  • Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adriakaim Inc
  • Afferent Technologies
  • Aucta Technologies Inc
  • AURIMOD GmbH
  • Boston Scientific Corp
  • Cala Health Inc
  • CerboMed GmbH
  • Cyberonics Inc
  • DuoCure Ltd.
  • ElectroCore Inc
  • Evren Technologies Inc
  • Flint Rehabilitation
  • FRD Accel LLC
  • LivaNova PLC
  • Medical University of South Carolina
  • MicroTransponder Inc
  • Nemechek Technologies LLC
  • Nexeon MedSystems Inc
  • Otto Bock HealthCare GmbH
  • Parasym Ltd
  • Pulsetto UAB
  • Pulsus Medical LLC (Inactive)
  • Purdue University
  • ReShape Lifesciences Inc
  • Soterix Medical Inc
  • SUNY Downstate Medical Center
  • Synergia Medical SA
  • Texas Biomedical Device Center
  • The Feinstein Institute for Medical Research
  • Trifectas Medical Corp.
  • University of Alabama
  • University of Auckland
  • University of Pittsburgh
  • University of Wisconsin Madison
  • VA Pittsburgh Healthcare System